[ Price : $8.95]
Sarepta Therapeutics announces that its gene therapy Elevidys significantly slowed disease progression over three years in ambulat...[ Price : $8.95]
AMT-130 is a gene therapy designed to lower levels of the mutant huntingtin protein believed to drive Huntingtons disease progress...[ Price : $8.95]
U.S., U.K. and Canadian drug regulators announce a joint international symposium to discuss evolving regulatory expectations for c...[ Price : $8.95]
A federal judge sentences former CytoDyn chief executive Nader Pourhassan to 30 months in prison for misleading investors about th...[ Price : $8.95]
FDA cites Pine Pharmaceuticals for multiple quality and sterility violations following a 10-day inspection of the companys drug ou...[ Price : $8.95]
FDA says it continued to improve the speed and consistency of drug manufacturing oversight in fiscal year 2024, citing strong perf...[ Price : $8.95]
FDA cites Asahi Kasei Finechem Co. for significant quality control deficiencies following a November inspection of the companys ac...[ Price : $8.95]
FDAs annual report on drug approvals says the majority of novel drugs approved in 2025 moved through accelerated regulatory pathwa...